Reuters - A single gene appears to play a crucial role in deadly breast cancers, increasing the chances the cancer will spread and making it resistant to chemotherapy, U.S. researchers said on Monday.

HealthDay - Here are some of the latest health and medical news developments, compiled by editors of HealthDay:

HealthDay - Here are some of the latest health and medical news developments, compiled by editors of HealthDay:

HealthDay - Here are some of the latest health and medical news developments, compiled by editors of HealthDay:

Reuters - Noscapine, a natural substance found in cough medicine, may prove useful in treating advanced prostate cancer, according to studies in mice.

Reuters - Younger age, symptoms of depression, and severe pain during the immediate post-operative period are significant predictors of severe pain during recovery from radical prostatectomy, study findings indicate.

HealthDay - MONDAY, Dec. 29 (HealthDay News) -- The injected drug degarelix has been approved by the U.S. Food and Drug Administration to treat advanced prostate cancer.

AP - Federal regulators on Monday said they have approved the first new drug to treat prostate cancer in several years.

Reuters - Men at higher-than-average risk of prostate cancer are more likely to seek regular screening if they are married or live with a significant other, a new study finds.

Reuters - An enlarged prostate due to benign prostatic hyperplasia, or BPH, can be safely and effectively removed using a type of minimally invasive single-keyhole surgery, researchers report.

HealthDay - (HealthDay News) -- As men age, the prostate gland often begins to swell -- which can cause uncomfortable symptoms. Men who have symptoms of an enlarged prostate should seek prompt medical treatment.

AP - Treating advanced prostate cancer with radiation and hormone-blocking drugs cut the death rate in half in a study of Scandinavian men, researchers report. In the United States, the combination has been standard care since the 1990s. But in Europe, many doctors have avoided the combo treatment and used hormone drugs alone, thinking the pair would be too harsh for most patients.

HealthDay - MONDAY, Dec. 15 (HealthDay News) -- Men with locally advanced prostate cancer -- cancer that has spread beyond the wall of the prostate gland -- who undergo radiation plus long-term hormone treatment cut their risk of dying in half, a new study has found.

Reuters - Adding radiation therapy to standard drug treatment can cut in half the death rate from advanced prostate cancer and should become the standard of care globally, Swedish researchers reported on Monday.

HealthDay - FRIDAY, Dec. 12 (HealthDay News) -- Information patients commonly receive about the risk of their breast cancer returning after surgery may make their decision on whether to get chemotherapy more difficult, a new study concludes.

HealthDay - THURSDAY, Dec. 11 (HealthDay News) -- Researchers continue to test the mettle of breakthrough breast cancer drugs, three decades after tamoxifen changed the medical landscape by drastically reducing the risk of recurrences in women with estrogen receptor-positive tumors.

Reuters - The Novartis bone-strengthening drug Zometa may enhance the effects of chemotherapy, shrinking breast tumors and helping more women avoid a mastectomy, British researchers said on Thursday.

HealthDay - TUESDAY, Dec. 9 (HealthDay News) -- Selenium, vitamin E and vitamin C won't prevent men from getting prostate cancer.

Reuters - Greek researchers have identified the chemotherapy combinations that appear to help women with advanced breast cancer live longest, they reported Tuesday.

AFP - Vitamins C and E do not appear to reduce the risk of cancer, according to a pair of new studies which debunk earlier research suggesting supplements might provide some protection against the often deadly ailment.